Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency;Fizjologiczne funkcje L-ornityny i L-asparaginianu oraz celowość podawania asparaginianu ornityny w stanach wzglȩdnego niedoboru

Polski Merkuriusz Lekarski

Volumn 28, Issue 168, 2010, Pages 490-495

  Sikorska, Hanna ^a   Cianciara, Janusz ^b   Wiercińska DrapaŁo, Alicja ^b  

^a Bio Assistance   (Canada)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Ammonia metabolism; L ornithine L aspartate; Liver diseases; Ornithine deficiency; Suplementation; Urea cycle

Indexed keywords

ASPARTIC ACID; ORNITHINE;

ANIMAL; ARTICLE; DISEASE MODEL; EXERCISE; FEMALE; HUMAN; METABOLISM; PHYSIOLOGY; PREGNANCY; UREA CYCLE DISORDER; WOUND HEALING;

ANIMALS; ASPARTIC ACID; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; ORNITHINE; PHYSICAL EXERTION; PREGNANCY; UREA CYCLE DISORDERS, INBORN; WOUND HEALING;

EID: 77954738300     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bachmann C., Colombo J.P.: Diagnostic value of orotic acid excretion in heritable disorders of the urea cycle and in hyperammonemia due to organic acidurias. Eur. J. Pediatr., 1980, 134, 2, 109-113.
2. Balasundaram D., Tabor C.W., Tabor H.: Spermidine or spermine is essential for the aerobic growth of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 1991, 88, 13, 5872-5876.
3. Banister E.W., Cameron B.J.: Exercise-Induced hyperammonemia: peripheral and central effects. Int J. Sports Med., 1990, 11 suppl. 2, S129-S142.
4. Barbul A.: Proline precursors to sustain Mammalian collagen synthesis. J. Nutr., 2008, 138, 10, 2021S-2024S.
5. Branconnier R.J., Dessain E.C, McNiff M.E. i wsp.: Blood ammonia and Alzheimer's disease. Am. J. Psychiatry, 1986, 143, 10, 1313-1314.
6. Brusilow S.W.: Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis. J. Clin. Invest, 1984, 74, 6, 2144-2148.
7. Bugianesi E.: Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Practice & Research. Clin. Gastroenterol., 2004. 18, 6, 1105-1116.
8. Castillo L., Sánchez M., Chapman T.E. i wsp.: The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake. Proc. Natl. Acad. Sci. USA, 1994, 91, 14, 6393-6397.
9. Cohen N.S., Cheung C.W. i Raijman L.: The effects of ornithine on mitochondrial carbamyi phosphate synthesis. J. Biol. Chem., 1980, 255, 21, 10248-10255.
10. Cohen N.S., Kyan F.S., Kyan S.S. i wsp.: The apparent Km of ammonia for carbamoyl phosphate synthetase (ammonia) in situ. Biochem. J., 1985, 229, 1, 205-211.
11. Cooper A.J., Plum F.: Biochemistry and physiology of brain ammonia. Physiol. Rev., 1987, 67, 2, 440-519.
12. Daune-Anglard G., Bonaventura N., Seiler N.: Some biochemical and pathophysiological aspects of long-term elevation of brain ornithine concentrations. Pharmacol. Toxicol., 1993, 73, 1, 29-34.
13. De Bandt J.P., Cynober L., Lim S.K. i wsp.: Metabolism of ornithine, alpha-ketoglutarate and arginine in isolated perfused rat liver. Br. J. Nutr., 1995, 73, 2, 227-239.
14. Diehl A.M., Abdo S. i Brown N.: Supplemental putrescine reverses ethanol-assoclated inhibition of liver regeneration. Hepatology, 1990, 12, 4 Pt 1, 633-637.
15. Fisman M., Gordon B., Feleki V. i wsp.: Hyperammonemia in Alzheimer's disease. Am. J. Psychiatry, 1985, 142, 1, 71-73.
16. Furst P.. Stehle P.: What Are the Essential Elements Needed for the Determination of Amino Acid Requirements in Humans? J. Nutr., 2004, 134, 6, 1558S-1565S.
17. Gordon B.A., Gatfield D.P. i Haust M.D.: The hyperornithinemia, hyperammonemia, homocitrullinuria syndrome: an ornithine transport defect remediable with ornithine supplements. Clin. Invest Med., 1987, 10, 4, 329-336.
18. Hems R., Ross B.D., Berry M.N. i wsp.: Gluconeogenesis in the perfused rat liver. Biochem. J., 1966, 101, 284-292.
19. Hoyer S., Nitsch R., Oesterreich K.: Ammonia is endogenously generated in the brain in the presence of presumed and verified dementia of Alzheimer type. Neurosa. Lett., 1990, 117, 3, 358-362.
20. International Diabetes Federation: The IDF Consensus Worldwide Definition of the Metabolic Syndrome, http://www.idf.org/webcast/pdf/1.
21. Janeczko D.: ZespóŁ metaboliczny - epidemia XXI wieku. Przeg. Lek., 2005, 3, 14-27.
22. Kesner L.: The effect of ammonia administration on orotic acid excretion in rats. J. Biol. Chem., 1965, 240, 1722-1724.
23. Kircheis G., Nilius R., Held C. i wsp.: Therapeutic efficacy of L-ornithineL-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology, 1997, 25, 6, 1351-1360.
24. Krebs H.A.: Urea formation in mammalian liver. Biochem. J., 1942, 36, 10-12, 758-767.
25. Krebs H.A., Hems R. i Lund P.: Some regulatory mechanisms in the synthesis of urea in the mammalian liver. Adv. Enzyme Regul., 1973, 11, 361-377.
26. Krebs H.A., Henseleit K.: Studies on urea formation in the animal organism. Untersuchungen über die Harnstoffbildung im Tierkörper. Z. Physiol. Chem., 1932, 210, 33-66.
27. Luk G.D.: Essential role of polyamine metabolism in hepatic regeneration. Inhibition of deoxyribonucleic add and protein synthesis and tissue regeneration by difluoromethytomithine in the rat. Gastroenterology, 1986, 90, 5 Pt 1, 1261-1267.
28. Lund P., Wiggins D.: The ornithine requirement of urea synthesis. Formation of ornithine from glutamina in hepatocytes. Biochem. J., 1986, 239, 3, 773-776.
29. Magdzik W.: Epidemiologia wirusowych zapaleń wa̧troby typu B i C w Polsce z uwzglȩdnieniem dzieci. Hepatol. Polska, 1997, supl. 1, 5-9.
30. Meijer A.J., Lamers W.H., Chamuleau R.A.: Nitrogen metabolism and ornithine cycle function. Physiol. Rev., 1990, 70, 3, 701-748.
31. Merz Pharmaceuticals GmbH: Hepa-Merz® - Liver diseases and hepatic encephalopathy. Scientific Product Monograph, 2002.
32. Minuk G.Y., Gauthier T., Benarroch A.: Changes in serum and hepatic polyamine concentrations after 30%, 70% and 90% partial hepatectomy in rats. Hepatology, 1990, 12, 3 R1, 542-546.
33. Muting D., Kalk J.F., Klein C.P.: Long-term effectiveness of high-dosed ornithine-aspartate on urea synthesis rate and portal hypertension in human liver cirrhosis. Amino Acids, 1992, 3, 2, 147-153.
34. Ogiso S., Matsumoto T., Nimura Y.: The role of polyamines In liver regeneration after hepatectomy with ischemic injury. Surg. Today, 1997, 27, 9, 833-839.
35. Pegg A.E.: Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res., 1988, 48, 4, 759-774.
36. Pegg A.E.: Regulation of ornithine decarboxylase. J. Biol. Chem., 2006, 281. 21, 14529-14532.
37. Rémésy C., Demigné C., Aufrere J.: Inter-organ relationships between glucose, lactate and amino acids in rats fed on high-carbohydrate or highprotein diets. Biochem. J., 1978, 170, 2, 321-329.
38. Seiler N., Daune G., Bolkenius F.N. i wsp.: Ornithine aminotransferase activity, tissue ornithine concentrations and polyamine metabolism. Int J. Biochem., 1989, 21, 4, 425-432.
39. Seiler N. i Daune-Anglard G.: Endogenous ornithine in search for CNS functions and therapeutic applications. Metab. Brain Dis., 1993, 8, 3, 151-179.
40. Shi H.P., Fishel R.S., Efron D.T. i wsp.: Effect of supplemental ornithine on wound healing. J. Surg. Res., 2002, 106, 2, 299-302.
41. Shih V.E.: Regulation of ornithine metabolism. Enzyme, 1981, 26, 5, 254-258.
42. Stauch S., Kircheis G., Adler G. i wsp.: Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J. Hepatol., 1998, 28, 5, 856-864.
43. Stetten M.R.: Mechanism of the conversion of ornithine into proline and glutamic acid in vivo. J. Biol. Chem., 1951, 189, 2, 499-507.
44. Sugino T., Shirai T., Kajimoto Y. i wsp.: L-omithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism. Nutr. Res., 2008, 28, 11, 738-743.
45. Vogel H.J.: Path of ornithine synthesis in Escherichia coli. Proc. Natl. Acad. Sci. USA, 1953, 39, 7, 578-583.
46. Zieve L.: Conditional deficiencies of ornithine or arginine. J. Am. Coll. Nutr., 1986, 5, 2, 167-176.